Vulvar Langerhans cell histiocytosis: Clinicopathologic characteristics, mutational profile, and treatment of 4 patients in a single-center cohort
JAAD Case Rep
.
2023 Apr 23:36:78-81.
doi: 10.1016/j.jdcr.2023.03.024.
eCollection 2023 Jun.
Authors
Ruben Renier
1
,
Petra De Haes
2
,
Francesca Bosisio
2
,
Isabelle Vanden Bempt
3
,
F J Sherida H Woei-A-Jin
4
Affiliations
1
KU Leuven, Department of Dermatology, Leuven, Belgium.
2
KU Leuven, Department of Pathology, Leuven, Belgium.
3
KU Leuven, Department of Human Genetics, Leuven, Belgium.
4
KU Leuven, University Hospitals Leuven, Department of General Medical Oncology, Leuven, Belgium.
PMID:
37250013
PMCID:
PMC10220460
DOI:
10.1016/j.jdcr.2023.03.024
No abstract available
Keywords:
BRAF; Langerhans cell histiocytosis; gene mutation; skin; treatment; vulva.
Publication types
Case Reports